Matches in Wikidata for { <http://www.wikidata.org/entity/Q64250229> ?p ?o ?g. }
- Q64250229 description "2019 թվականին հրատարակված գիտական հոդված" @default.
- Q64250229 description "article scientifique (publié 2019)" @default.
- Q64250229 description "articolo scientifico (pubblicato il 2019)" @default.
- Q64250229 description "artigo científico (publicado na 2019)" @default.
- Q64250229 description "artikull shkencor i botuar më 01 janar 2019" @default.
- Q64250229 description "artículo científico publicado en 2019" @default.
- Q64250229 description "artículu científicu espublizáu en xineru de 2019" @default.
- Q64250229 description "im Jahr 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q64250229 description "scientific article published on 01 January 2019" @default.
- Q64250229 description "wetenschappelijk artikel" @default.
- Q64250229 description "наукова стаття, опублікована в січні 2019" @default.
- Q64250229 description "научна статия" @default.
- Q64250229 name "Peripheral Venous Blood Platelet-to-Lymphocyte Ratio (PLR) for Predicting the Survival of Patients With Gastric Cancer Treated With SOX or XELOX Regimen Neoadjuvant Chemotherapy" @default.
- Q64250229 name "Peripheral Venous Blood Platelet-to-Lymphocyte Ratio (PLR) for Predicting the Survival of Patients With Gastric Cancer Treated With SOX or XELOX Regimen Neoadjuvant Chemotherapy" @default.
- Q64250229 name "Peripheral Venous Blood Platelet-to-Lymphocyte Ratio" @default.
- Q64250229 type Item @default.
- Q64250229 label "Peripheral Venous Blood Platelet-to-Lymphocyte Ratio (PLR) for Predicting the Survival of Patients With Gastric Cancer Treated With SOX or XELOX Regimen Neoadjuvant Chemotherapy" @default.
- Q64250229 label "Peripheral Venous Blood Platelet-to-Lymphocyte Ratio (PLR) for Predicting the Survival of Patients With Gastric Cancer Treated With SOX or XELOX Regimen Neoadjuvant Chemotherapy" @default.
- Q64250229 label "Peripheral Venous Blood Platelet-to-Lymphocyte Ratio" @default.
- Q64250229 prefLabel "Peripheral Venous Blood Platelet-to-Lymphocyte Ratio (PLR) for Predicting the Survival of Patients With Gastric Cancer Treated With SOX or XELOX Regimen Neoadjuvant Chemotherapy" @default.
- Q64250229 prefLabel "Peripheral Venous Blood Platelet-to-Lymphocyte Ratio (PLR) for Predicting the Survival of Patients With Gastric Cancer Treated With SOX or XELOX Regimen Neoadjuvant Chemotherapy" @default.
- Q64250229 prefLabel "Peripheral Venous Blood Platelet-to-Lymphocyte Ratio" @default.
- Q64250229 P1433 Q64250229-FAAC074B-A9FD-4551-8D21-EC4E3495493D @default.
- Q64250229 P1476 Q64250229-10DF89FA-9161-4044-9619-593F4AC4E2B3 @default.
- Q64250229 P2093 Q64250229-0B44C331-A3CC-46EB-B1CE-BB1932CF344B @default.
- Q64250229 P2093 Q64250229-0DD3AAC0-2836-4744-801D-E3CFCDE3FC99 @default.
- Q64250229 P2093 Q64250229-25E1E8F8-50C6-4D1F-8A3C-8CFBAE93B073 @default.
- Q64250229 P2093 Q64250229-5DBFB63B-1F97-4601-8F36-19DC863170CB @default.
- Q64250229 P2093 Q64250229-8F2F06F4-490A-4242-9CCE-7433A8D04FBF @default.
- Q64250229 P2093 Q64250229-A67CC1C2-7842-44A4-BB7D-5B6AAC40E917 @default.
- Q64250229 P2093 Q64250229-E6D8FA80-16FF-45D2-B639-08FCF223E5F1 @default.
- Q64250229 P2860 Q64250229-08932C61-26F8-4DD2-86F8-06DD5AEEA07A @default.
- Q64250229 P2860 Q64250229-26A3021B-616B-4629-8224-1022D793EE76 @default.
- Q64250229 P2860 Q64250229-27F6681F-0646-47B4-9673-EEA74E88C7EE @default.
- Q64250229 P2860 Q64250229-29A5378A-E0D7-4903-9BB7-AF2B9B577778 @default.
- Q64250229 P2860 Q64250229-29AA61B8-4412-4870-8D00-3E8B214E23C6 @default.
- Q64250229 P2860 Q64250229-4B6EAC0F-0157-41FC-8566-BE9E94CEC9D2 @default.
- Q64250229 P2860 Q64250229-4F468196-E5A1-4DA1-874C-8C2B8AC86178 @default.
- Q64250229 P2860 Q64250229-50E332BF-A90E-4D53-9537-025586FDE4D8 @default.
- Q64250229 P2860 Q64250229-7A6000E9-0586-4785-8A1A-1B1DE8246085 @default.
- Q64250229 P2860 Q64250229-99A02354-E544-490D-87F6-E5D513D02F72 @default.
- Q64250229 P2860 Q64250229-A44FF191-C31E-4A0F-B55C-F8F213DE62BE @default.
- Q64250229 P2860 Q64250229-A92D827F-3C00-4008-9850-EB08F6426A36 @default.
- Q64250229 P2860 Q64250229-AFBB6C2D-3071-481A-A061-A4CAA457174B @default.
- Q64250229 P2860 Q64250229-B21A81E0-706B-431A-A031-80311FA980C2 @default.
- Q64250229 P2860 Q64250229-B41B2D16-440C-4397-8536-8D441ECF643A @default.
- Q64250229 P2860 Q64250229-B609813F-35F5-4A28-89D3-C80D6817409A @default.
- Q64250229 P2860 Q64250229-C3890FBD-913C-4632-9B0D-EA040BF31FD9 @default.
- Q64250229 P2860 Q64250229-CA010B03-CFC1-43B9-8B72-04D420EADA1F @default.
- Q64250229 P2860 Q64250229-CCE84032-781C-46B6-AA1F-12ABD74984D3 @default.
- Q64250229 P2860 Q64250229-CFA0D601-2883-4539-8636-637395742039 @default.
- Q64250229 P2860 Q64250229-DAFE6D44-0ADD-4B34-9E81-592F9B5EFB4D @default.
- Q64250229 P2860 Q64250229-E1E15747-9494-483F-BFD8-937DA962EE87 @default.
- Q64250229 P2860 Q64250229-EA6540A1-CA20-424C-9FC2-91D5FBA048B8 @default.
- Q64250229 P304 Q64250229-A2C95F0A-DF04-4E87-BE09-C7B2D88EA180 @default.
- Q64250229 P31 Q64250229-6D3A4656-6099-49E2-BE4C-D7D001F18419 @default.
- Q64250229 P356 Q64250229-519D0127-8C61-43F7-9424-EDB6D9169E77 @default.
- Q64250229 P407 Q64250229-E2EFF9A7-35E3-4300-8341-BFD0E1E407F8 @default.
- Q64250229 P478 Q64250229-07632AA2-9BFB-40B2-938D-DDF714CA7731 @default.
- Q64250229 P50 Q64250229-25C6A772-C34E-4BDB-B248-4A7FEFBD90B7 @default.
- Q64250229 P577 Q64250229-C0AEAB67-ED66-476C-8E6E-49F0B7444E63 @default.
- Q64250229 P698 Q64250229-3C205ECE-56C2-4206-86FC-B3857F70A419 @default.
- Q64250229 P932 Q64250229-FEE7F7EC-5159-4C5F-8327-FDF9AEF4B8B9 @default.
- Q64250229 P356 1533033819829485 @default.
- Q64250229 P698 30760114 @default.
- Q64250229 P1433 Q15755758 @default.
- Q64250229 P1476 "Peripheral Venous Blood Platelet-to-Lymphocyte Ratio (PLR) for Predicting the Survival of Patients With Gastric Cancer Treated With SOX or XELOX Regimen Neoadjuvant Chemotherapy" @default.
- Q64250229 P2093 "Li Chen" @default.
- Q64250229 P2093 "Lihua Zhu" @default.
- Q64250229 P2093 "Menghua Zou" @default.
- Q64250229 P2093 "Sen Li" @default.
- Q64250229 P2093 "Xiliang Cong" @default.
- Q64250229 P2093 "Ying Hao" @default.
- Q64250229 P2093 "Yingwei Xue" @default.
- Q64250229 P2860 Q22252312 @default.
- Q64250229 P2860 Q26797427 @default.
- Q64250229 P2860 Q27860501 @default.
- Q64250229 P2860 Q27860907 @default.
- Q64250229 P2860 Q27861048 @default.
- Q64250229 P2860 Q28088619 @default.
- Q64250229 P2860 Q28131668 @default.
- Q64250229 P2860 Q33755032 @default.
- Q64250229 P2860 Q34634936 @default.
- Q64250229 P2860 Q35847903 @default.
- Q64250229 P2860 Q37046529 @default.
- Q64250229 P2860 Q37580326 @default.
- Q64250229 P2860 Q37805788 @default.
- Q64250229 P2860 Q38157342 @default.
- Q64250229 P2860 Q38647855 @default.
- Q64250229 P2860 Q39258789 @default.
- Q64250229 P2860 Q44441494 @default.
- Q64250229 P2860 Q45217260 @default.
- Q64250229 P2860 Q53319621 @default.
- Q64250229 P2860 Q55053470 @default.
- Q64250229 P2860 Q77780546 @default.
- Q64250229 P2860 Q84302553 @default.
- Q64250229 P2860 Q86501367 @default.
- Q64250229 P304 "1533033819829485" @default.
- Q64250229 P31 Q13442814 @default.
- Q64250229 P356 "10.1177/1533033819829485" @default.